Confidence intervals and sample size planning for optimal cutpoints. [PDF]
Thiele C, Hirschfeld G.
europepmc +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Biomechanical Reconstruction with Confidence Intervals from Multiview Markerless Motion Capture. [PDF]
Cotton RJ, Sinz F.
europepmc +1 more source
Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials. [PDF]
Scharpenberg M, Brannath W.
europepmc +1 more source
Elevated Connectivity During Language Processing Is Associated With Cognitive Performance in SeLECTS
ABSTRACT Objective Self‐Limited Epilepsy with Centrotemporal Spikes (SeLECTS) is associated with language impairments despite seizures originating in the motor cortex, suggesting aberrant cross‐network interactions. Here we tested whether functional connectivity in SeLECTS during language tasks predicts language performance.
Wendy Qi +8 more
wiley +1 more source
An empirical Bayes approach for constructing confidence intervals for clonality and entropy. [PDF]
Chen Z, Tian L, Olshen RA.
europepmc +1 more source
ABSTRACT Objective Stereoelectroencephalography‐guided radiofrequency thermocoagulation (SEEG‐RFTC) has emerged as a safe and effective minimally invasive treatment for children with drug‐resistant focal epilepsy. Although evidence from real‐world studies remains limited, numerous pediatric cases have demonstrated promising outcomes. This retrospective
Weitao Chen +7 more
wiley +1 more source
Confidence Intervals for Adaptive Trial Designs II: Case Study and Practical Guidance. [PDF]
Robertson DS +6 more
europepmc +1 more source
Permutation-based multiple testing corrections for $$ P $$ -values and confidence intervals for cluster randomized trials. [PDF]
Watson SI, Akinyemi JO, Hemming K.
europepmc +1 more source
Relationship Between Neurologic Symptoms and Signs and FMR1 Genotype in Premutation Carriers
ABSTRACT Background and Objectives Fragile X‐associated Tremor/Ataxia Syndrome (FXTAS) is the most severe late‐onset condition caused by a premutation in the FMR1 gene, characterized by expanded CGG triplet repeats of 55–200. Clinical presentations of FXTAS, including gait ataxia, kinetic tremor, cognitive decline, and rare Parkinsonism, are linked to ...
Flora Tassone +8 more
wiley +1 more source

